Prosecution Insights
Last updated: November 20, 2026

Joseph Rankin Spangler, USPTO Patent Examiner

Listed by the USPTO as SPANGLER, JOSEPH RANKIN

Tech Center 1600 • Art Units: 1656

This examiner grants 42% of resolved cases

Analysis

SPANGLER, JOSEPH RANKIN has 72 resolved cases in Tech Center 1600 and Art Unit 1656. The allowance rate is 41.7%, while the interview lift is 71.3%. The median time to allowance is 1346 days.

The listed companies are Toray Industries Inc., Chr. Hansen A/S, and Inbiose N V. The listed firms are BIRCH STEWART KOLASCH & BIRCH, LLP, Meunier Carlin & Curfman LLC, and TRASKBRITT, P.C. The interview measure is prominent relative to the allowance result, making interview preparation a practical consideration, although the resolved-case history remains limited.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

41.7%
Allow Rate
-18.3% vs TC avg
114
Total Applications
+71.3%
Interview Lift
1346
Avg Prosecution Days
Based on 72 resolved cases, 2023–2026

Rejection Statute Breakdown

11.7%
§101 Eligibility
12.8%
§102 Novelty
33.8%
§103 Obviousness
23.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18197579 BIOANALYSIS OF THERAPEUTIC ANTIBODIES AND RELATED PRODUCTS USING IMMUNOPRECIPITATION AND NATIVE SEC-PCD-MS DETECTION Non-Final OA Regeneron Pharmaceuticals, Inc.
18863697 GENETICALLY MODIFIED YEAST AND FERMENTATION PROCESSES FOR THE PRODUCTION OF XYLITOL Non-Final OA Cargill, Incorporated
17609841 GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS Non-Final OA TORAY INDUSTRIES, INC.
17609964 GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS Non-Final OA TORAY INDUSTRIES, INC.
17514264 Fibrosis Assay Final Rejection Georgia Tech Research Corporation
17415344 ASPARAGINASE-INDUCED GLUTAMINE DEPLETION COMBINED WITH BCL-2 INHIBITION FOR TREATMENT OF HEMATOLOGIC AND SOLID CANCERS Final Rejection UNIVERSITY OF MARYLAND, BALTIMORE
18558943 SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF Non-Final OA Yale University
17602367 METHOD AND APPARATUS FOR PURIFYING BLOOD Final Rejection B. Braun Avitum AG
17613904 METHODS OF MONITORING CELL CULTURE MEDIA Non-Final OA Bristol-Myers Squibb Company
19048825 FLAVONOID GLYCOSIDE GLYCOSYLTRANSFERASE LbUGT71BX1 IN LAPORTEA BULBIFERA AS WELL AS THE CODING GENE AND THE USE THEREOF Non-Final OA INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES
17634909 TEXTURING L. LACTIS WITH UNIQUE EPS GENE CLUSTERS Non-Final OA Chr. Hansen A/S
16769964 SPRAY-DRIED SIALYLLACTOSE Final Rejection Chr. Hansen A/S
18835750 CELLULOSE-SYNTHETIZING MICROBE TRANSFECTANT AND USE THEREOF Non-Final OA NATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Joseph Rankin Spangler's allowance rate?

41.7% of resolved applications examined by Joseph Rankin Spangler were allowed (72 resolved cases), compared with 44.3% across Art Unit 1656 over the last five years.

Does an interview help with examiner Joseph Rankin Spangler?

This examiner's interview lift is +71.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Joseph Rankin Spangler take to allow a patent?

Applications allowed by Joseph Rankin Spangler took 1,346 days on average from filing to allowance.

Which art unit does examiner Joseph Rankin Spangler work in?

Joseph Rankin Spangler examines applications in Art Unit 1656 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month